Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1,336.55
- Piotroski Score 4.00
- Grade N/A
- Symbol (LIPO)
- Company Lipella Pharmaceuticals Inc.
- Price $0.39
- Changes Percentage (-6.14%)
- Change -$0.03
- Day Low $0.39
- Day High $0.42
- Year High $2.71
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/27/2024
- Fiscal Year End N/A
- Average Stock Price Target $2.00
- High Stock Price Target $2.00
- Low Stock Price Target $2.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.74
- Trailing P/E Ratio -0.88
- Forward P/E Ratio -0.88
- P/E Growth -0.88
- Net Income $-4,618,965
Income Statement
Quarterly
Annual
Latest News of LIPO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Why Drew Barrymore stopped her show to eat a lollipop off the floor
Newsweek's network of contributors share entertainment gossip and news, including Drew Barrymore's playful interaction with guest 50 Cent on her show. Barrymore shocked 50 Cent with a $500 lollipop, l...
By Newsweek | 2 weeks ago -
Galipolo, picked to run Brazil's central bank, is heterodox economist
Gabriel Galipolo, a 42-year-old economist nominated to head Brazil's central bank, brings heterodox views but gained acceptance for his competence and rapport with President Lula. He is seen as a prom...
By Yahoo! Finance | 1 month ago -
Lula Taps Ally Gabriel Galipolo as Brazil Central Bank Chief
Brazil's President Lula appointed Gabriel Galipolo as the new central bank chief, aiming to influence the institution's policies on high interest rates. Galipolo, a former adviser to Lula, will face c...
By Yahoo! Finance | 1 month ago
